Answer
Propafenone hydrochloride is contraindicated in patients with significant structural heart disease because, as with some other class Ic anti-arrhythmic agents, these patients may be predisposed to serious adverse events.
Sources for this answer
- Arythmol 150mg TabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §4.4 Special warnings and precautions for use · Version 24Document updated
Sources checked